Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
RVC to run epilepsy diet trial
College to investigate the effect of diet on canine condition

The Royal Veterinary College (RVC) is to run a new trial, which will investigate the effect of diet on canine idiopathic epilepsy. Holger Andreas Volk, an RVC lecturer and clinical director at the centre, said: “The influence of diet on epilepsy severity and quality of life is established in humans, with many diets having been shown to improve seizure control. 


“However, there is little data to support the use of diets in veterinary medicine. A new diet has been developed that could improve the management of epileptic dogs, not only by reducing seizure frequency, but especially by improving quality of life and decreasing the level of side effects seen with standard antiepileptic drugs."

The newly developed diet is being trialled on epileptic dogs being treated with phenobarbitone and/or potassium bromide, in order to test its efficacy and safety.

Staff at the college, however, have only managed to recruit half the sample size they need to test the diet, and are now calling on vets and vet nurses to suggest any patients they believe are suitable. Volk added: “We need your help to recruit more dogs. The food is very well tolerated and liked by the dogs on the study.”

According to staff, participating dogs must be aged between 6 months and 11 years old, have had at least three seizures in the last three months and be receiving at least phenobarbital. They must also be suspected of having idiopathic epilepsy, including an unremarkable MRI, and be in good general health, with an unremarkable interictal.

For more information on the trial, the RVC have asked vets and vet nurses to email the Clinical Investigations Centre.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com